Variant report
Variant | esv2763462 |
---|---|
Chromosome Location | chr5:68295338-68307023 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CCDC125-4 | chr5:68297895-68297899 | NONHSAT101876 |
2 | lnc-CCDC125-14 | chr5:68301385-68301502 | ucscGeneNc_uc003jvf_1 |
3 | lnc-CCDC125-14 | chr5:68300126-68300527 | ucscGeneNc_uc003jvf_1 |
4 | lnc-CCDC125-14 | chr5:68301696-68302660 | ucscGeneNc_uc003jvf_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375655507 | chr5:68295473-68295474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185030981 | chr5:68295474-68295475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553079059 | chr5:68295492-68295493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571371019 | chr5:68295516-68295517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147749174 | chr5:68295551-68295552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556722772 | chr5:68295553-68295554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542898434 | chr5:68295563-68295564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs3138743 | chr5:68295564-68295565 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs371057529 | chr5:68295565-68295566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375010533 | chr5:68295566-68295567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs58742138 | chr5:68295596-68295597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62354499 | chr5:68295602-68295603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369890433 | chr5:68295625-68295626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192812055 | chr5:68295669-68295670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374657807 | chr5:68295677-68295678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6888622 | chr5:68295686-68295687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs576219155 | chr5:68295731-68295732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113471842 | chr5:68295745-68295746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564991167 | chr5:68295770-68295771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6888650 | chr5:68295773-68295774 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs11949644 | chr5:68295785-68295786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562785970 | chr5:68295796-68295797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530810385 | chr5:68295804-68295805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528943730 | chr5:68295806-68295807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189506999 | chr5:68295820-68295821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567589704 | chr5:68295828-68295829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59441940 | chr5:68295843-68295844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376385549 | chr5:68295902-68295903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs59351555 | chr5:68295914-68295915 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs145340357 | chr5:68295916-68295917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181497473 | chr5:68295947-68295948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574535805 | chr5:68295975-68295976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184619642 | chr5:68295976-68295977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552486972 | chr5:68295977-68295978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374564406 | chr5:68295979-68295980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568796065 | chr5:68296035-68296036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563299500 | chr5:68296086-68296087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554813525 | chr5:68296088-68296089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs55657218 | chr5:68296105-68296106 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs534086732 | chr5:68296121-68296122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558764508 | chr5:68296146-68296147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577262776 | chr5:68296187-68296188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531238122 | chr5:68296245-68296246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377134083 | chr5:68296289-68296290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562882994 | chr5:68296358-68296359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189183676 | chr5:68296365-68296366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542250023 | chr5:68296377-68296378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561128212 | chr5:68296393-68296394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7732834 | chr5:68296445-68296446 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs75441733 | chr5:68296453-68296454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Lung cancer | 17086460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68292000-68296200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr5:68296200-68298000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr5:68298000-68301600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr5:68300200-68300800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr5:68300400-68300600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:68300400-68300600 | Enhancers | Fetal Lung | lung |
7 | chr5:68300400-68301000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr5:68300600-68302800 | Weak transcription | Fetal Lung | lung |
9 | chr5:68301600-68303000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr5:68302400-68303600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr5:68302800-68303400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr5:68302800-68303400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr5:68302800-68303400 | Enhancers | Fetal Lung | lung |
14 | chr5:68303000-68303200 | Bivalent Enhancer | Fetal Brain Female | brain |
15 | chr5:68303000-68303600 | Enhancers | Brain Hippocampus Middle | brain |
16 | chr5:68303000-68303800 | Enhancers | Brain Cingulate Gyrus | brain |
17 | chr5:68305000-68305400 | Enhancers | Pancreas | Pancrea |
18 | chr5:68305400-68305800 | Weak transcription | Pancreas | Pancrea |
19 | chr5:68305800-68306000 | Enhancers | Pancreas | Pancrea |
20 | chr5:68306000-68307000 | Weak transcription | Pancreas | Pancrea |
21 | chr5:68307000-68307400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr5:68307000-68308000 | Enhancers | Pancreas | Pancrea |